Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker BHC
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BHC Bausch Health Companies Inc. | Nomura Global Financial Products Inc | 15.71M | 4.2% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | BHC Bausch Health Companies Inc. | Nomura Holdings Inc | 15.71M | 4.2% | SCHEDULE 13G/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Carl C. Icahn | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Beckton Corp. | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Enterprises G.P. Inc. | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Enterprises Holdings L.P. | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Iph GP LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Capital LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Onshore LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Partners LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Offshore LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 15, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Partners Master Fund LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | BHC Bausch Health Companies Inc. | Steven A. Tananbaum | 35.24M | 9.5% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | BHC Bausch Health Companies Inc. | GoldenTree Asset Management LLC | 34.25M | 9.3% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | BHC Bausch Health Companies Inc. | GoldenTree Asset Management LP | 34.25M | 9.3% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Paulson & Co. Inc. | 70.76M | 19.1% | SCHEDULE 13D/A ↗ |
| Jun 17, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Paulson & Co. Inc. | 32.79M | 8.9% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Carl C. Icahn | 34.72M | 9.4% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Beckton Corp. | 34.72M | 9.4% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Enterprises G.P. Inc. | 34.72M | 9.4% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Enterprises Holdings L.P. | 34.72M | 9.4% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Iph GP LLC | 34.72M | 9.4% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Capital LP | 34.72M | 9.4% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Onshore LP | 20.30M | 5.5% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Partners LP | 20.30M | 5.5% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Offshore LP | 14.42M | 3.9% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Icahn Partners Master Fund LP | 14.42M | 3.9% | SCHEDULE 13D/A ↗ |
| May 21, 2025 | SCHEDULE 13D/A (amended) | BHC Bausch Health Companies Inc. | Paulson & Co. Inc. | 26.44M | 7.1% | SCHEDULE 13D/A ↗ |
| May 15, 2025 | SCHEDULE 13G | BHC Bausch Health Companies Inc. | Nomura Global Financial Products Inc | 23.39M | 6.3% | SCHEDULE 13G ↗ |
| May 15, 2025 | SCHEDULE 13G | BHC Bausch Health Companies Inc. | Nomura Holdings Inc | 23.39M | 6.3% | SCHEDULE 13G ↗ |
| Apr 7, 2025 | SCHEDULE 13D | BHC Bausch Health Companies Inc. | Alex Meruelo | 36.76M | 10.0% | SCHEDULE 13D ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances